NZ has 'lost sight of opportunity' says Trans-Tasman Resources boss, as iwi and environment group cautiously welcome backdown. Fox Meyer and Jonathan Milne reports.
OKYO Pharma Limited has filed for Fast Track designation with the U.S. FDA for its drug urcosimod, aimed at treating neuropathic corneal pain, a painful eye condition currently lacking an FDA-approved ...
It's outdated evidence that has sunk the Taranaki consent application, as the fast-track panel refuses to ‘kick the can down ...
Urcosimod is currently being evaluated in a phase 2 trial evaluating it's efficacy and safety in adults with neuropathic corneal pain. OKYO Pharma has filed a Fast Track designation application with ...
ANAHEIM, CA, July 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related ...
June 7 (UPI) --China has agreed to fast-track approvals for the shipment of rare earth minerals to the United States and some European Union nations. U.S. President Donald Trump and Chinese leader Xi ...